Indivior Pharmaceuticals (INDV) Margins & Profitability 2024-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 85.7%
EBITDA Margin: 50.8%
Op. Margin: 50.6%
Net Margin: 38.5%

Op. margin of 50.6% is up 36.9% YoY — cost efficiency is improving. Net margin at 38.5% and gross margin of 85.7% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit